Literature DB >> 22116525

Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year.

Luis F Guerrero1, Juan C Rueda, Raquel Arciniegas, Jorge M Rueda.   

Abstract

The aim of the study is to evaluate the clinical and serological features of patients with undifferentiated connective tissue disease (UCTD) of a rheumatology referral center in Cali, Colombia, who were followed for a year. A retrospective analysis of a cohort of patients with an initial diagnosis of UCTD and monitoring for at least 12 months was carried out. A total of 94 patients with UCTD (97.9% women) were evaluated, with an average follow-up of 51 ± 35.7 months. Only 13 patients (13.8%) evolved into a defined connective tissue disease (CTD), of which 8.5% (n:8) developed systemic lupus erythematosus (SLE), 4.2% (n:4) Sjögren syndrome (SS) and 1.1% (n:1) rheumatoid arthritis (RA). A mean period of 35.8 ± 29.2 months between UCTD diagnosis and definite develop of a CTD was found. Arthritis, Raynaud's phenomenon and photosensitivity were statistically significant (<0.001) for development of CTD. After a mean follow-up of 4.25 years, most of the patients with UCTD showed a favorable evolution. Arthritis, Raynaud's phenomenon and the presence of photosensitivity were predictors for the development of CTD. It requires a consensus to establish criteria for the classification of UCTD.

Entities:  

Mesh:

Year:  2011        PMID: 22116525     DOI: 10.1007/s00296-011-2234-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

Review 1.  Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.

Authors:  M Mosca; R Neri; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

2.  Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases.

Authors:  M G Danieli; P Fraticelli; F Franceschini; R Cattaneo; A Farsi; A Passaleva; M Pietrogrande; F Invernizzi; M Vanoli; R Scorza; M G Sabbadini; R Gerli; A Corvetta; G Farina; F Salsano; R Priori; G Valesini; G Danieli
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

3.  Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD.

Authors:  M G Danieli; P Fraticelli; A Salvi; A Gabrielli; G Danieli
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years.

Authors:  Marta Mosca; Rossella Neri; Walter Bencivelli; Antonio Tavoni; Stefano Bombardieri
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

5.  Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients.

Authors:  I Cavazzana; F Franceschini; N Belfiore; M Quinzanini; R Caporali; P Calzavara-Pinton; L Bettoni; A Brucato; R Cattaneo; C Montecucco
Journal:  Clin Exp Rheumatol       Date:  2001 Jul-Aug       Impact factor: 4.473

6.  Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year.

Authors:  M Mosca; A Tavoni; R Neri; W Bencivelli; S Bombardieri
Journal:  Lupus       Date:  1998       Impact factor: 2.911

7.  Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.

Authors:  J Calvo-Alen; G S Alarcon; S L Burgard; N Burst; A A Bartolucci; H J Williams
Journal:  J Rheumatol       Date:  1996-03       Impact factor: 4.666

8.  Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients.

Authors:  C C Vaz; M Couto; D Medeiros; L Miranda; J Costa; P Nero; R Barros; M J Santos; E Sousa; A Barcelos; L Inês
Journal:  Clin Rheumatol       Date:  2009-04-24       Impact factor: 2.980

Review 9.  Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology.

Authors:  Marta Mosca; Chiara Tani; Stefano Bombardieri
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-12       Impact factor: 4.098

10.  One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up.

Authors:  E Simmons-O'Brien; S Chen; R Watson; C Antoni; M Petri; M Hochberg; M B Stevens; T T Provost
Journal:  Medicine (Baltimore)       Date:  1995-05       Impact factor: 1.889

View more
  5 in total

Review 1.  Preclinical lupus.

Authors:  Rebecka Bourn; Judith A James
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

Review 2.  Differentiating between UCTD and early-stage SLE: from definitions to clinical approach.

Authors:  Savino Sciascia; Dario Roccatello; Massimo Radin; Ioannis Parodis; Jinoos Yazdany; Guillermo Pons-Estel; Marta Mosca
Journal:  Nat Rev Rheumatol       Date:  2021-11-11       Impact factor: 20.543

3.  The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus.

Authors:  James Mossell; John A Goldman; Derren Barken; Roberta Vezza Alexander
Journal:  Open Rheumatol J       Date:  2016-10-31

4.  A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial.

Authors:  Shaoying Yang; Ruoning Ni; Yikang Lu; Suli Wang; Feng Xie; Chunyan Zhang; Liangjing Lu
Journal:  Trials       Date:  2020-09-09       Impact factor: 2.279

5.  Acute fibrinous and organizing pneumonia and undifferentiated connective tissue disease: a case report.

Authors:  Valéria Valim; Roberta Hora Rocha; Roberta Barcelos Couto; Thaysa Simões Paixão; Erica Vieira Serrano
Journal:  Case Rep Rheumatol       Date:  2012-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.